Development of oxoisoaporphine derivatives with topoisomerase I inhibition and reversal of multidrug resistance in breast cancer MCF-7/ADR cells.
A series of oxoisoaporphine derivatives with topoisomerase I inhibition and cytotoxic activities....
Read More